189 related articles for article (PubMed ID: 35755386)
1. First-in-Class Star-Shaped Triazine Dendrimers Endowed with MMP-9 Inhibition and VEGF Suppression Capacity: Design, Synthesis, and Anticancer Evaluation.
Haiba NS; Khalil HH; Bergas A; Abu-Serie MM; Khattab SN; Teleb M
ACS Omega; 2022 Jun; 7(24):21131-21144. PubMed ID: 35755386
[TBL] [Abstract][Full Text] [Related]
2. Engineered s-Triazine-Based Dendrimer-Honokiol Conjugates as Targeted MMP-2/9 Inhibitors for Halting Hepatocellular Carcinoma.
Khalil HH; Osman HA; Teleb M; Darwish AI; Abu-Serie MM; Khattab SN; Haiba NS
ChemMedChem; 2021 Dec; 16(24):3701-3719. PubMed ID: 34547831
[TBL] [Abstract][Full Text] [Related]
3. Halting Tumor Progression via Novel Non-Hydroxamate Triazole-Based Mannich Bases MMP-2/9 Inhibitors; Design, Microwave-Assisted Synthesis, and Biological Evaluation.
Albelwi FF; Teleb M; Abu-Serie MM; Moaty MNAA; Alsubaie MS; Zakaria MA; El Kilany Y; Aouad MR; Hagar M; Rezki N
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638665
[TBL] [Abstract][Full Text] [Related]
4. Battle tactics against MMP-9; discovery of novel non-hydroxamate MMP-9 inhibitors endowed with PI3K/AKT signaling attenuation and caspase 3/7 activation via Ugi bis-amide synthesis.
Ayoup MS; Fouad MA; Abdel-Hamid H; Ramadan ES; Abu-Serie MM; Noby A; Teleb M
Eur J Med Chem; 2020 Jan; 186():111875. PubMed ID: 31740054
[TBL] [Abstract][Full Text] [Related]
5. Targeting the interplay between MMP-2, CA II and VEGFR-2 via new sulfonamide-tethered isomeric triazole hybrids; Microwave-assisted synthesis, computational studies and evaluation.
Reda Aouad M; Almehmadi MA; Faleh Albelwi F; Teleb M; Tageldin GN; Abu-Serie MM; Hagar M; Rezki N
Bioorg Chem; 2022 Jul; 124():105816. PubMed ID: 35489270
[TBL] [Abstract][Full Text] [Related]
6. Halting colorectal cancer metastasis via novel dual nanomolar MMP-9/MAO-A quinoxaline-based inhibitors; design, synthesis, and evaluation.
Ayoup MS; Abu-Serie MM; Awad LF; Teleb M; Ragab HM; Amer A
Eur J Med Chem; 2021 Oct; 222():113558. PubMed ID: 34116327
[TBL] [Abstract][Full Text] [Related]
7. Structure-based design and optimization of pyrimidine- and 1,2,4-triazolo[4,3-a]pyrimidine-based matrix metalloproteinase-10/13 inhibitors via Dimroth rearrangement towards targeted polypharmacology.
El Ashry ESH; Awad LF; Teleb M; Ibrahim NA; Abu-Serie MM; Abd Al Moaty MN
Bioorg Chem; 2020 Mar; 96():103616. PubMed ID: 32032847
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of human leukocyte elastase, plasmin and matrix metalloproteinases by oleic acid and oleoyl-galardin derivative(s).
Moroy G; Bourguet E; Decarme M; Sapi J; Alix AJ; Hornebeck W; Lorimier S
Biochem Pharmacol; 2011 Mar; 81(5):626-35. PubMed ID: 21146503
[TBL] [Abstract][Full Text] [Related]
9. Matrix Metalloproteinases (MMPs) in Targeted Drug Delivery: Synthesis of a Potent and Highly Selective Inhibitor against Matrix Metalloproteinase- 7.
Wang LL; Zhang B; Zheng MH; Xie YZ; Wang CJ; Jin JY
Curr Top Med Chem; 2020; 20(27):2459-2471. PubMed ID: 32703131
[TBL] [Abstract][Full Text] [Related]
10. In silico study combining docking and QSAR methods on a series of matrix metalloproteinase 13 inhibitors.
Xi L; Li S; Yao X; Wei Y; Li J; Liu H; Wu X
Arch Pharm (Weinheim); 2014 Nov; 347(11):825-33. PubMed ID: 25363411
[TBL] [Abstract][Full Text] [Related]
11. MMP-2 alters VEGF expression via alphaVbeta3 integrin-mediated PI3K/AKT signaling in A549 lung cancer cells.
Chetty C; Lakka SS; Bhoopathi P; Rao JS
Int J Cancer; 2010 Sep; 127(5):1081-95. PubMed ID: 20027628
[TBL] [Abstract][Full Text] [Related]
12. PPARgamma ligands and ATRA inhibit the invasion of human breast cancer cells in vitro.
Liu H; Zang C; Fenner MH; Possinger K; Elstner E
Breast Cancer Res Treat; 2003 May; 79(1):63-74. PubMed ID: 12779083
[TBL] [Abstract][Full Text] [Related]
13. An appraisal of cinnamyl sulfonamide hydroxamate derivatives (HDAC inhibitors) for anti-cancer, anti-angiogenic and anti-metastatic activities in human cancer cells.
Reddy ND; Shoja MH; Biswas S; Nayak PG; Kumar N; Rao CM
Chem Biol Interact; 2016 Jun; 253():112-24. PubMed ID: 27163855
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of enzyme activity of and cell-mediated substrate cleavage by membrane type 1 matrix metalloproteinase by newly developed mercaptosulphide inhibitors.
Hurst DR; Schwartz MA; Jin Y; Ghaffari MA; Kozarekar P; Cao J; Sang QX
Biochem J; 2005 Dec; 392(Pt 3):527-36. PubMed ID: 16026329
[TBL] [Abstract][Full Text] [Related]
15. 2-Methylpyridine-1-ium-1-sulfonate from Allium hirtifolium: An anti-angiogenic compound which inhibits growth of MCF-7 and MDA-MB-231 cells through cell cycle arrest and apoptosis induction.
Mohammadi-Motlagh HR; Shokohinia Y; Mojarrab M; Rasouli H; Mostafaie A
Biomed Pharmacother; 2017 Sep; 93():117-129. PubMed ID: 28624423
[TBL] [Abstract][Full Text] [Related]
16. Enzymatic inhibitory activity of iridoid glycosides from Picrorrhiza kurroa against matrix metalloproteinases: Correlating in vitro targeted screening and docking.
Rathee D; Lather V; Grewal AS; Dureja H
Comput Biol Chem; 2019 Feb; 78():28-36. PubMed ID: 30497018
[TBL] [Abstract][Full Text] [Related]
17. A bi-specific inhibitor targeting IL-17A and MMP-9 reduces invasion and motility in MDA-MB-231 cells.
Koslawsky D; Zaretsky M; Alcalay R; Mazor O; Aharoni A; Papo N
Oncotarget; 2018 Jun; 9(47):28500-28513. PubMed ID: 29983876
[TBL] [Abstract][Full Text] [Related]
18. Novel molecular discovery of promising amidine-based thiazole analogues as potent dual Matrix Metalloproteinase-2 and 9 inhibitors: Anticancer activity data with prominent cell cycle arrest and DNA fragmentation analysis effects.
Omar AM; Bajorath J; Ihmaid S; Mohamed HM; El-Agrody AM; Mora A; El-Araby ME; Ahmed HEA
Bioorg Chem; 2020 Aug; 101():103992. PubMed ID: 32554279
[TBL] [Abstract][Full Text] [Related]
19. Gallic acid-capped gold nanoparticles inhibit EGF-induced MMP-9 expression through suppression of p300 stabilization and NFκB/c-Jun activation in breast cancer MDA-MB-231 cells.
Chen YJ; Lee YC; Huang CH; Chang LS
Toxicol Appl Pharmacol; 2016 Nov; 310():98-107. PubMed ID: 27634460
[TBL] [Abstract][Full Text] [Related]
20. New thieno[3,2-d]pyrimidine-based derivatives: Design, synthesis and biological evaluation as antiproliferative agents, EGFR and ARO inhibitors inducing apoptosis in breast cancer cells.
Farghaly AM; AboulWafa OM; Baghdadi HH; Abd El Razik HA; Sedra SMY; Shamaa MM
Bioorg Chem; 2021 Oct; 115():105208. PubMed ID: 34365057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
